Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

por Lentz, S R, Ehrenforth, S, Abdul Karim, F, Matsushita, T, Weldingh, K N, Windyga, J, Mahlangu, J N, For the Adept™2 Investigators
Publicado 2014